Lilly to boost diabetes sales force

Eli Lilly said it expects to increase its diabetes sales force by 40% in 2007. The move comes as Lilly plans launch five new insulin pen delivery products and bolster efforts behind its recently launched diabetes treatment Byetta, Lilly president John Lechleiter told investors last Thursday. Byetta’s new-prescription volume increased 30% over the last month, Lilly said. The drug also recently won approval to be marketed in Europe.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions